| Daniel Wee, MD | |
|
1899 W March Ln, Stockton, CA 95207-6402 | |
| (209) 623-4700 | |
| (209) 623-4700 |
| Full Name | Daniel Wee |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 18 Years |
| Location | 1899 W March Ln, Stockton, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740480441 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | C139388 (California) | Primary |
| 207W00000X | Ophthalmology | 036.127414 (Illinois) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Center For Sight Of Stockton A Medical Corporation | 2264499037 | 4 |
News Archive
An agency within the U.S. Department of Health and Human Services that maintains a discipline and medical-malpractice database reopened it for public access yesterday, two months after the agency had first taken the database offline.
Heart enlargement caused by narrowed aortic valves regresses faster in elderly women than in men after aortic valve replacement, according to research reported in a surgical supplement of Circulation: Journal of the American Heart Association.
Women who suffer from incontinence or pelvic organ prolapse from obesity, heavy lifting, smoking, chronic constipation or childbirth don't always need surgery according to a pioneering British medical device manufacturer.
Generex Biotechnology Corporation today announced that it has reached a pre-specified point in the ongoing Phase II trial of its AE37 breast cancer vaccine to initiate its primary efficacy analysis. The drug is a novel immunotherapeutic cancer vaccine being developed by the Company's wholly-owned subsidiary, Antigen Express, Inc. A previously released positive interim analysis showed a strong trend toward reduced relapse in breast cancer patients receiving the AE37 vaccine.
› Verified 2 days ago
| Entity Name | Center For Sight Of Stockton A Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962426643 PECOS PAC ID: 2264499037 Enrollment ID: O20050714000703 |
News Archive
An agency within the U.S. Department of Health and Human Services that maintains a discipline and medical-malpractice database reopened it for public access yesterday, two months after the agency had first taken the database offline.
Heart enlargement caused by narrowed aortic valves regresses faster in elderly women than in men after aortic valve replacement, according to research reported in a surgical supplement of Circulation: Journal of the American Heart Association.
Women who suffer from incontinence or pelvic organ prolapse from obesity, heavy lifting, smoking, chronic constipation or childbirth don't always need surgery according to a pioneering British medical device manufacturer.
Generex Biotechnology Corporation today announced that it has reached a pre-specified point in the ongoing Phase II trial of its AE37 breast cancer vaccine to initiate its primary efficacy analysis. The drug is a novel immunotherapeutic cancer vaccine being developed by the Company's wholly-owned subsidiary, Antigen Express, Inc. A previously released positive interim analysis showed a strong trend toward reduced relapse in breast cancer patients receiving the AE37 vaccine.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Wee, MD 1899 W March Ln, Stockton, CA 95207-6402 Ph: (209) 623-4700 | Daniel Wee, MD 1899 W March Ln, Stockton, CA 95207-6402 Ph: (209) 623-4700 |
News Archive
An agency within the U.S. Department of Health and Human Services that maintains a discipline and medical-malpractice database reopened it for public access yesterday, two months after the agency had first taken the database offline.
Heart enlargement caused by narrowed aortic valves regresses faster in elderly women than in men after aortic valve replacement, according to research reported in a surgical supplement of Circulation: Journal of the American Heart Association.
Women who suffer from incontinence or pelvic organ prolapse from obesity, heavy lifting, smoking, chronic constipation or childbirth don't always need surgery according to a pioneering British medical device manufacturer.
Generex Biotechnology Corporation today announced that it has reached a pre-specified point in the ongoing Phase II trial of its AE37 breast cancer vaccine to initiate its primary efficacy analysis. The drug is a novel immunotherapeutic cancer vaccine being developed by the Company's wholly-owned subsidiary, Antigen Express, Inc. A previously released positive interim analysis showed a strong trend toward reduced relapse in breast cancer patients receiving the AE37 vaccine.
› Verified 2 days ago
Dr. Stephen Andrew Lin, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 36 West Yokuts Ave, Suite 1, Stockton, CA 95207 Phone: 209-952-3700 Fax: 209-478-3302 | |
Dr. Charles Kim, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1899 W March Ln, Stockton, CA 95207 Phone: 209-623-4700 Fax: 209-623-4710 | |
Dr. Daniel Edward Levinsohn, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 1899 W March Ln, Stockton, CA 95207 Phone: 209-623-4706 Fax: 209-623-4716 | |
Dr. John C. Canzano, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 255 E Weber Ave, Stockton, CA 95202 Phone: 209-466-5566 Fax: 209-466-0535 | |
Josepha Mensah-adubofour, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 7373 West Ln, Stockton, CA 95210 Phone: 209-476-2000 | |
On-tat Lee, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1617 Saint Marks Plz Ste D, Stockton, CA 95207 Phone: 209-478-1797 Fax: 209-478-1224 | |
Dr. Robert Scott Foster, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 36 West Yokuts Ave, Ste 1, Stockton, CA 95207 Phone: 209-952-3700 Fax: 209-478-3302 |